LMP-420

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameLMP-420
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A